Ruby Biopharma Private Limited

This company manufactures, sells, and exports pharmaceuticals for human and animal healthcare, including basic drug intermediates and herbal medicines.

2008 | Mumbai, Maharashtra (India) | Active
Last Updated:

Ruby Biopharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 17 Year, 1 Month
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.40 Cr
  • Revenue Growth 2.26%
  • Profit Growth 74.06%
  • Ebitda 74.89%
  • Net Worth 21.32%
  • Total Assets 14.88%

About Ruby Biopharma

Ruby Biopharma Private Limited (RBPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 21 January 2008 and has a history of 17 years and one month. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.

The company currently has active open charges totaling ₹11.40 Cr.

Rumy Kumar and Ruby Kumar serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24234MH2008PTC178070

  • Company No.

    178070

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    21 Jan 2008

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Ruby Biopharma?

Board Members (2)

NameDesignationAppointment DateStatus
Rumy Kumar Country flag representing In Director 21-Jan-2008Current
Ruby Kumar Country flag representing In Director 21-Jan-2008Current

Financial Performance of Ruby Biopharma.

Ruby Biopharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.26% increase. The company also saw a substantial improvement in profitability, with a 74.06% increase in profit. The company's net worth Soared by an impressive increase of 21.32%.

Ruby Biopharma revenue growth over time
Ruby Biopharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
2.26%
Revenue from Operations
1.99%
Total Assets
14.88%
Profit or Loss
74.06%
Net Worth
21.32%
EBITDA
74.89%

What is the Ownership and Shareholding Structure of Ruby Biopharma?

In 2023, Ruby Biopharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹114.00 M

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

  • Axis Bank Limited : 11.40 Cr

Latest Charge Details

DateLenderAmountStatus
21 Mar 2024Axis Bank Limited₹6.00 CrOpen
04 Mar 2024Axis Bank Limited₹5.40 CrOpen

How Many Employees Work at Ruby Biopharma?

Ruby Biopharma has a workforce of 3 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee growth trends for Ruby Biopharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ruby Biopharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ruby Biopharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Ruby Biopharma

Recent activity within the organization

  • Annual General Meeting

    Ruby Biopharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

  • Balance Sheet

    Ruby Biopharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 60.00 M with Charge ID 100894143 was registered on 21 Mar 2024.

  • Charges

    A charge with Axis Bank Limited amounted to Rs. 54.00 M with Charge ID 100886643 was registered on 04 Mar 2024.

  • Director Appointment

    Rumy Ravi Kumar was appointed as a Director was appointed as a Director on 21 Jan 2008 & has been associated with this company since 17 years 1 month .

  • Director Appointment

    Ruby Ravi Kumar was appointed as a Director was appointed as a Director on 21 Jan 2008 & has been associated with this company since 17 years 1 month .

Frequently asked questions

  • What is the Incorporation or founding date of Ruby Biopharma Private Limited?

    Ruby Biopharma Private Limited was incorporated on 21 Jan 2008.

  • What is authorized share capital and paid-up capital of Ruby Biopharma Private Limited?

    The authorized share capital of Ruby Biopharma Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.15 M.

  • Who are the current board members & directors of Ruby Biopharma Private Limited?

    Currently 2 directors are associated with Ruby Biopharma Private Limited.

    • Rumy Ravi Kumar
    • Ruby Ravi Kumar

  • What is the registered address of Ruby Biopharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Ruby Biopharma Private Limited is 11A Sandeep Park Deonar India, Mumbai, Maharashtra, 400088.

  • What is the corporate identification number (CIN) and company number of Ruby Biopharma Private Limited?

    The corporate identification number (CIN) of Ruby Biopharma Private Limited is U24234MH2008PTC178070 and the company number is 178070 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Ruby Biopharma Private Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Ruby Biopharma Private Limited has risen by 2.26%.

  • How many employees does Ruby Biopharma Private Limited currently have?

    As Per 2023 financial reports, 3 employees are currently employed by Ruby Biopharma Private Limited.

  • What change has been observed in the net worth of Ruby Biopharma Private Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Ruby Biopharma Private Limited has experienced an upsurge of 21.32%.

  • What are the total open charges for Ruby Biopharma Private Limited?

    As per the financial statements for fiscal Year 2023, The total open charges for Ruby Biopharma Private Limited amount to ₹ 11.40 Cr.

  • When was the last Balance Sheet of Ruby Biopharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Ruby Biopharma Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development